Biocon Q2 results: Net profit drops 22% on higher R&D cost; revenue jumps 10%

Biocon reported a 10% rise in total revenue to Rs 1,760 crore driven by overall growth in generics, biosimilar and research services businesses.

from Markets-Economic Times https://ift.tt/2Hqa30S